Sen. Bill Cassidy’s report calls on Congress to improve program transparency, like requiring covered entities to show how they use 340B funds. Drug groups praised the findings, while hospitals argued the analysis was limited in scope.
Sen. Bill Cassidy’s report calls on Congress to improve program transparency, like requiring covered entities to show how they use 340B funds. Drug groups praised the findings, while hospitals argued the analysis was limited in scope.